[go: up one dir, main page]

AU2020901776A0 - Use of Aminoacetonitrile compounds for the treatment of infection and disease - Google Patents

Use of Aminoacetonitrile compounds for the treatment of infection and disease

Info

Publication number
AU2020901776A0
AU2020901776A0 AU2020901776A AU2020901776A AU2020901776A0 AU 2020901776 A0 AU2020901776 A0 AU 2020901776A0 AU 2020901776 A AU2020901776 A AU 2020901776A AU 2020901776 A AU2020901776 A AU 2020901776A AU 2020901776 A0 AU2020901776 A0 AU 2020901776A0
Authority
AU
Australia
Prior art keywords
infection
disease
treatment
aminoacetonitrile compounds
aminoacetonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020901776A
Inventor
Roger Aston
Richard Mollard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pitney Pharmaceuticals Pty Ltd
Original Assignee
Pitney Pharmaceuticals Pty Ltd
Filing date
Publication date
Application filed by Pitney Pharmaceuticals Pty Ltd filed Critical Pitney Pharmaceuticals Pty Ltd
Publication of AU2020901776A0 publication Critical patent/AU2020901776A0/en
Priority to PCT/AU2021/050435 priority Critical patent/WO2021226662A1/en
Priority to JP2022569454A priority patent/JP2023528229A/en
Priority to CA3183094A priority patent/CA3183094A1/en
Priority to EP21804737.1A priority patent/EP4149454A4/en
Priority to AU2021272252A priority patent/AU2021272252A1/en
Priority to US17/924,537 priority patent/US12213957B2/en
Abandoned legal-status Critical Current

Links

AU2020901776A 2020-05-11 2020-05-29 Use of Aminoacetonitrile compounds for the treatment of infection and disease Abandoned AU2020901776A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PCT/AU2021/050435 WO2021226662A1 (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infection and disease
JP2022569454A JP2023528229A (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infections and diseases
CA3183094A CA3183094A1 (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infection and disease
EP21804737.1A EP4149454A4 (en) 2020-05-11 2021-05-11 USE OF AMINOACETONITRILE COMPOUNDS FOR THE TREATMENT OF INFECTION AND DISEASE
AU2021272252A AU2021272252A1 (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infection and disease
US17/924,537 US12213957B2 (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infection and disease

Publications (1)

Publication Number Publication Date
AU2020901776A0 true AU2020901776A0 (en) 2020-06-18

Family

ID=

Similar Documents

Publication Publication Date Title
GB201907616D0 (en) Novel compounds and pharmaceutical compositons thereof for the treatment of diseases
EP4117694A4 (en) Microbial consortia for the treatment of disease
PH12020551905A1 (en) C-mannoside compounds useful for the treatment of urinary tract infections
AU2022298746A1 (en) Beta-lactam derivatives for the treatment of diseases
EP4110344A4 (en) Use of thyromimetics for the treatment of cancer
EP4149451A4 (en) Cysteamine for the treatment of sars-cov-2 infection
EP3911160A4 (en) Treatment of plants against disease
EP4103195A4 (en) Treatment of infectious diseases
EP4232458A4 (en) Compounds and methods for the treatment of ocular disorders
EP4193995A4 (en) Use of btk inhibitors in the treatment of diseases
EP4138852A4 (en) Compositions and methods for the treatment of pain
EP4100404A4 (en) Methods and compounds for the treatment of genetic disease
AU2020901776A0 (en) Use of Aminoacetonitrile compounds for the treatment of infection and disease
EP3789019A4 (en) Composition for prevention or treatment of skin infection
EP4324495A4 (en) Blood treatment material
AU2020901514A0 (en) Use of aminoacetonitrile compounds for the treatment of disease
EP4217355A4 (en) Agents for the treatment of diseases by inhibition of foxo1
EP3996655A4 (en) Medical device solutions for treating dental disease and methods for the treatment of dental disease
EP4025212B8 (en) Isoxazole-3-carboxamide derivatives and their use for treatment of diseases caused by virus infection
EP4048678A4 (en) Compounds and compositions for the treatment of parasitic diseases
EP4154856A4 (en) Disposable diaper
AU2021903178A0 (en) Treatment of VEGFA-Related Disease
AU2020903576A0 (en) Treatment of VEGFA-Related Disease
EP4125844A4 (en) Use of fenretinide for the treatment of sars-corona virus infection
EP4121035A4 (en) Use of bucillamine in the treatment of infectious diseases